INTRODUCTION
============

Endocrine-disrupting chemicals (EDCs) are exogenous compounds that perturb the physiology of the endocrine glandular tissue ([@b37-molce-41-12-1052]). These compounds can disturb hormone production, release, transport, and metabolism ([@b18-molce-41-12-1052]). Routes of human exposure are varied owing to the wide array of applications and sources rich in EDCs. Transdermal absorption from cosmetics and personal hygiene products, ingestion in drinking water and food packaging material, and inhalation in dust represent the major and most common forms of exposure that carry the greatest risk potential ([@b10-molce-41-12-1052]). Furthermore, the developing neuroendocrine tissue of neonates is constantly being exposed to high concentrations of EDCs in breast milk and infant formula ([@b2-molce-41-12-1052]; [@b13-molce-41-12-1052]), implicating these xenobiotics in developmental, neurological, and reproductive anomalies ([@b33-molce-41-12-1052]).

Classification of EDCs is complicated as the number of newly identified, and erroneously recognized compounds, continues to steadily grow. Although many remain insufficiently characterized, phenolic EDCs are among the most common and well-studied classes. A prominent example is triclosan (TCS); an antimicrobial extensively used in the manufacture of plastics, toys, cosmetics, and kitchenware ([Fig. 1A](#f1-molce-41-12-1052){ref-type="fig"}). TCS has also been used for decades in hospital settings as an antiseptic and a disinfectant ([@b7-molce-41-12-1052]; [@b32-molce-41-12-1052]). The antimicrobial activity of TCS is attributed to the compound's interference with the enzyme enoyl-acyl carrier protein reductase (FabI), which is required for fatty acid and biotin biosynthesis ([@b32-molce-41-12-1052]). Beside its antimicrobial properties, TCS toxicity has been studied in various living systems including humans, and the chemical has been shown to build up in body fluids including blood, urine, and breast milk ([@b13-molce-41-12-1052]; [@b32-molce-41-12-1052]). Due to its widespread use and high chlorine content, TCS and its derivatives are ubiquitous in soil and aquatic environments, and have been detected in wastewater treatment systems as well as drinking water sources ([@b4-molce-41-12-1052]; [@b12-molce-41-12-1052]; [@b20-molce-41-12-1052]; [@b23-molce-41-12-1052]).

The nematode *Caenorhabditis elegans* (*C. elegans*) has emerged as an attractive model animal for functional analysis of various bioactive compounds ([@b15-molce-41-12-1052]; [@b16-molce-41-12-1052]; [@b39-molce-41-12-1052]). Recent reports have shown that TCS exposure increased the mortality and infertility of wild-type *C. elegans* worms in a dose-dependent manner ([@b14-molce-41-12-1052]; [@b19-molce-41-12-1052]; [@b41-molce-41-12-1052]; [@b45-molce-41-12-1052]). To date, although significant progress has been made in our understanding of TCS toxicity, studies devoted to the identification of clinically or industrially relevant TCS inhibitors are extremely scarce. In this study, we demonstrate that nonionic surfactants (NISs), such as Tween 20 (Tw20), Tween 80 (Tw80), NP-40, and Triton X-100 (TX100), act as potent antagonists of phenolic EDCs, including TCS, bisphenol A (BPA), and benzyl 4-hydroxybenzoic acid (B4HB). Mechanistic analyses revealed that NISs inhibit TCS-induced mortality by micellar solubilization, and that internalized TCS-micelle complex appears to be exported by PMP-3 (encoding an ATP-binding cassette (ABC) transporter) protein. Given the concerns surrounding TCS exposure, our findings may provide an innovative approach to reduce the burden of TCS on ecosystems and human health alike.

MATERIALS AND METHODS
=====================

Chemicals and reagents
----------------------

All chemicals used in this study were purchased from Sigma Aldrich (MO, USA) and were of analytical grade. TCS and benzyl 4-hydroxybenzoic acid (B4HB) were prepared in ethanol as 0.1 M stock solutions. Bisphenol A (BPA) was dissolved in methanol to obtain a 0.1 M stock solution, while 0.1 M stock solutions of sodium dodecyl sulfate (SDS) and sodium azide (NaN~3~) were made in distilled water.

Strains and maintenance
-----------------------

*C. elegans* wild-type Bristol isolate (N2) and *pmp-3(ok1087)* mutant worms were obtained from the Caenorhabditis Genetics Center (CGC). All strains were cultured at 20°C in nematode growth medium (NGM) as previously described ([@b5-molce-41-12-1052]).

Toxicity assays
---------------

Embryos were obtained by sodium hypochlorite (0.5 M NaOH and 1.2% NaClO) treatment of gravid hermaphrodites and incubated in M9 buffer (22 mM KH~2~PO~4~, 42 mM Na~2~HPO, 86 mM NaCl, and 1 mM MgSO~4~) at 20°C overnight, as described elsewhere ([@b46-molce-41-12-1052]). Hatched L1 animals were either exposed to chemicals or were allowed to grow to adults on NGM plates for 3 days at 20°C before exposure. All chemicals were diluted in M9 or M9/0.1% NISs to the final testing concentrations. Treatment groups were compared to the vehicle control, which did not exceed 0.2% in each case. The mortality rate was calculated visually by counting live and dead worms using a bright field microscope ([Fig. 1B](#f1-molce-41-12-1052){ref-type="fig"}). Live worms exhibited normal locomotive behavior ([Fig. 1C](#f1-molce-41-12-1052){ref-type="fig"}), whereas dead worms were nonmotile and appeared rod-like in shape ([Fig. 1D](#f1-molce-41-12-1052){ref-type="fig"}).

Antimicrobial susceptibility testing
------------------------------------

*E. coli* OP50 bacteria were grown at 37°C for 5 h in Lysogeny Broth (LB) medium. Exposure was conducted in the same medium supplemented with TCS ranging from 0.001 mM to 0.05 mM with or without 0.1% Tw20. The optical density (OD~600~) was measured spectrophotometrically every two hours as an indicator of bacterial growth.

Pharyngeal pumping rate
-----------------------

Wild-type adult worms were incubated for 1 h at 25°C in M9 buffer with or without 0.1% Tw20, before they were plated on NGM and examined for pumping using a dissecting microscope. Grinder movements were monitored for one minute, and the number of pumps per minute (ppm) was recorded.

Disruption of intracellular micelles
------------------------------------

NIS micelles were heat-disrupted at 35°C. Following TCS treatment with or without 0.1% Tw20, two approaches were followed for micelle disruption ([Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}). In method I, worms were immediately incubated at 35°C for an additional hour, whereas in method II, removal of extracellular TCS-Tw20 complexes by sequential washing in M9 buffer preceded incubation at 35°C.

Statistical analysis
--------------------

Results are expressed as arithmetic means ± SD of at least three independent replicates (n \> 300). Comparative assessments between control and treatment groups were conducted using the paired *t*-student test. Statistical significance was determined by a *p* value of less than 0.05.

RESULTS
=======

TCS increases mortality dose-dependently
----------------------------------------

Amongst phenolic EDCs, we initially investigated TCS due to its widespread occurrence and well-documented toxicity ([@b32-molce-41-12-1052]) ([Fig. 1A](#f1-molce-41-12-1052){ref-type="fig"}). In eukaryotes, TCS disrupts mitochondrial oxidative phosphorylation and leads to profoundly increased reactive oxygen species (ROS) ([@b43-molce-41-12-1052]). Also, we have recently reported that TCS induces toxicity, at least in part, by disrupting the SKN-1 (SKiNhead-1)/NRF2 (erythroid-2-related factor 2)-mediated oxidative stress response in both *C. elegans* and human stem cells ([@b45-molce-41-12-1052]).

To initially determine the effect of TCS on *C. elegans* mortality, synchronized L1 larvae were treated with varying concentrations of TCS (0, 0.125, 0.25, 0.5, 1, 2, and 4 mM) for 1 h at 25°C. As shown in [Fig. 1E](#f1-molce-41-12-1052){ref-type="fig"}, the mortality rate of L1 worms increased in a dose-dependent manner with a TCS concentration of half maximal response (EC~50~) of \~0.2 mM. A similar dose-dependent pattern of increased mortality was also observed in adult worms ([Fig. 1F](#f1-molce-41-12-1052){ref-type="fig"}). These results suggest that TCS significantly increased the mortality of wild-type (N2) worms in a dose-dependent manner.

NISs abrogate TCS-induced mortality
-----------------------------------

Hydrophobic substances can be emulsified in micelles formed by NISs such as Tw20 ([@b21-molce-41-12-1052]), and the benzene ring in TCS imparts a hydrophobic nature to the antiseptic ([@b30-molce-41-12-1052]). To test the hypothesis that TCS-induced mortality could be neutralized by NISs, both L1 larvae and adult worms were treated with 0.125--8 mM TCS in the absence or presence of 0.1% Tw20 for 1 h at 25°C, and the mortality rate of both groups was calculated. Interestingly, co-treatment of TCS and Tw20 led to a profound decrease in the mortality of both stages when compared to TCS alone ([Figs. 2A](#f2-molce-41-12-1052){ref-type="fig"} and [Supplementary Fig. S1A](#s1-molce-41-12-1052){ref-type="supplementary-material"}). The highest TCS concentration susceptible to 0.1% Tw20 was around 8 mM and 4 mM for L1 larvae and adult worms, respectively ([Figs. 2A](#f2-molce-41-12-1052){ref-type="fig"} and [Supplementary Fig. S1A](#s1-molce-41-12-1052){ref-type="supplementary-material"}).

Ingestion in *C. elegans* is accomplished through the pharynx, and requires two sequential events; pumping and peristalsis. Pharyngeal movement is related to food intake, and is influenced by environmental conditions in the immediate vicinity of the worm ([@b36-molce-41-12-1052]). Thus, we examined if the protective role of Tw20 is related to restricted pharyngeal pumping. Which would hinder TCS uptake. To this end, adults were exposed to 0.1% Tw20 or left untreated for 1 h at 25°C. Worms were then plated and grinder movements (number of pumps per minute) were recorded under a differential interference contrast (DIC) microscope. Our results showed no significant difference in the rate of pharyngeal pumping in the absence or presence of Tw20 ([Fig. 2B](#f2-molce-41-12-1052){ref-type="fig"}), which indicates that Tw20 does not neutralize TCS toxicity by reducing its physical intake.

To determine the minimum effective concentration of Tw20 required to confer protection against lethal concentrations of TCS, L1 larvae were incubated for 1 h with 1, 2, and 4 mM TCS in the absence or presence of 0.1, 0.02, 0.004, and 0.0008 % Tw20. As for L1 larvae, at least 0.02% Tw20 was sufficient to protect against 4 mM TCS, while 0.004% Tw20 was sufficient against 1 mM TCS ([Fig. 2C](#f2-molce-41-12-1052){ref-type="fig"}). Parallel to L1 larvae, the mortality rate of adult worms at 1 and 2 mM TCS was significantly abrogated with at least 0.004% and 0.02% Tw20, respectively ([Supplementary Fig. S1B](#s1-molce-41-12-1052){ref-type="supplementary-material"}).

Next, we tested the effects of other NISs, including Tw80, NP-40, and TX100 on TCS-induced mortality. To this end, L1 staged wild-type worms were incubated with or without 0.5 mM TCS (a minimum concentration with \>80% mortality) in the absence or presence of 0.1--0.0008% Tw80, NP-40, or TX100 for 1 h at 25°C, and the mortality rate was calculated as described earlier. As seen in [Fig. 2D](#f2-molce-41-12-1052){ref-type="fig"}, all NISs tested significantly protected the worms against 0.5 mM TCS dose-dependently. In industrial settings, anionic surfactants such as sodium dodecyl sulfate (SDS) are also added to commercial products to solubilize TCS ([@b3-molce-41-12-1052]). In order to determine if SDS is also capable of antagonizing TCS toxicity, we incubated L1 larvae with 0.5 mM TCS in the presence of 1, 10, and 20 mM SDS for 1 h at 25°C and scored the mortality rate. SDS was found to be lethal to worms at 10 and 20 mM ([Fig. 2D](#f2-molce-41-12-1052){ref-type="fig"}). Although 1 mM SDS was not toxic, it nonetheless failed to protect against TCS ([Fig. 2D](#f2-molce-41-12-1052){ref-type="fig"}). This suggests that TCS-induced mortality is abrogated by co-treatment of NISs (i.e. Tw20, Tw80, NP-40, and TX100), but not by SDS.

We then sought to inquire whether Tw20 could also neutralize the antimicrobial activity of TCS. To this end, *E. coli* bacteria were cultured with or without 0.001--0.2 mM TCS in the absence or presence of 0.1% Tw20 for 24 h at 25°C. We specifically cultured *E. coli* bacteria at 25°C, instead of 37°C, to preserve the micellar state of Tw20. Optical density at 2-hour intervals was measured as a function of bacterial growth. Although TCS unsurprisingly inhibited bacterial growth at all concentrations tested, significant resistance was observed under conditions of a combination of 0.001 mM TCS and 0.1% Tw20 ([Fig. 2E](#f2-molce-41-12-1052){ref-type="fig"}, compare (3) and (7)). These findings suggest that the inhibitory action of NISs against TCS is also effective in bacteria at a certain concentration.

NISs mitigate the toxicity induced by other phenolic EDCs: BPA and B4HB
-----------------------------------------------------------------------

To assess the range of compounds sensitive to NIS interference, we tested the effect of NISs on other toxicants that are not recognized as EDCs ([Fig. 3A](#f3-molce-41-12-1052){ref-type="fig"}, left). Sodium azide (NaN~3~) is a polar, ionic salt commonly used as a solution preservative owing to its biocidal properties ([@b17-molce-41-12-1052]). It interferes with mitochondrial oxidative phosphorylation by chelating iron ions required for cytochrome oxidase activity ([@b17-molce-41-12-1052]). We evaluated the ability of NISs to subvert sodium azide toxicity by incubating L1 larvae with or without 0.2--1.6 mM sodium azide, in the absence or presence of 0.1% NISs for 24 h at 25°C. [Fig. 3B](#f3-molce-41-12-1052){ref-type="fig"} shows that the dose-responsive increase in mortality was not nullified by co-treatment with NISs. Ethanol (EtOH) is another polar compound with disruptive behavioral effects on *C. elegans* ([@b9-molce-41-12-1052]) ([Fig. 3A](#f3-molce-41-12-1052){ref-type="fig"}, left). To test whether NISs could protect against EtOH toxicity, L1 larvae were incubated with or without 10%--20% EtOH in the absence or presence of 0.1% NISs for 1 h at 25°C, and the mortality rate was subsequently scored. Our data show that 20% EtOH resulted in 100% mortality in wild-type worms which was not reversed by co-treatment with 0.1% NISs ([Fig. 3C](#f3-molce-41-12-1052){ref-type="fig"}).

Although we cannot exclude all other possibilities, these results indicate that molecular similarity among compounds may be a determining factor in their susceptibility to NISs. Hence, we examined two other chemicals that are closely related to TCS in terms of both their chemical nature (a common phenol ring) and activity (endocrine disruption) -- Bisphenol A (BPA) and Benzyl 4-hydroxybenzoic acid (B4HB) ([Fig. 3A](#f3-molce-41-12-1052){ref-type="fig"}, right). The xenoestrogenic activity of BPA is associated with increased proliferation of ovarian and breast cancer cells ([@b11-molce-41-12-1052]), genotoxicity ([@b31-molce-41-12-1052]), and elevated prolactin, estradiol, and progesterone levels in females ([@b25-molce-41-12-1052]). B4HB is a paraben widely used as a preservative in cosmetics and food processing ([@b44-molce-41-12-1052]). Exposure to parabens has been strongly linked to human health concerns mainly due to their estrogenicity and proliferative stimulation of breast cancer cells ([@b6-molce-41-12-1052]). Moreover, butylparaben has been shown to cause DNA damage in human sperm ([@b24-molce-41-12-1052]). To test if NISs could protect against BPA-induced mortality, L1 larvae were incubated with or without 0.5--2.0 mM BPA in the absence or presence of 0.1% NISs for 24 h at 25°C. In agreement with previous reports ([@b42-molce-41-12-1052]), BPA caused a dose-dependent increase in mortality and, interestingly, co-treatment with 0.1% NISs significantly ablated BPA-induced mortality ([Fig. 3D](#f3-molce-41-12-1052){ref-type="fig"}). We also determined the mortality of B4HB and its sensitivity to NIS inhibition. To this end, L1 larvae were incubated with or without 0.25--1.0 mM B4HB in the absence or presence of 0.1% NISs for 1 h at 25°C. As shown in [Fig. 3E](#f3-molce-41-12-1052){ref-type="fig"}, B4HB resulted in a significant, dose-dependent increase in mortality at all concentrations tested. Interestingly, a similar pattern of inhibition to TCS and BPA was also observed in worms co-treated with B4HB and NISs ([Fig. 3E](#f3-molce-41-12-1052){ref-type="fig"}). Taken together, these results suggest that NISs may protect against phenolic EDCs that share structural similarity to TCS.

Micellar solubilization is required for NIS-mediated protection
---------------------------------------------------------------

We next tested if NISs could inhibit the toxicity of TCS via micelle formation. Tw20 was chosen as a representative NIS as it showed potent inhibitory action against TCS concentration with 100% mortality ([Fig. 2A](#f2-molce-41-12-1052){ref-type="fig"}). To this end, L1 larvae were incubated with or without 1 mM TCS in the absence or presence of 0.1% Tw20 for 1 h at 25°C (optimal temperature for micelle formation) ([Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}). As observed earlier, 1 mM TCS resulted in 100% mortality, which was reversed by co-treatment with 0.1% Tw20 ([Fig. 4B](#f4-molce-41-12-1052){ref-type="fig"}, *Pre-incubation*). To evaluate the importance of micellar solubilization for the anti-toxic activity of Tw20, micelles were heat-disrupted by upshifting exposure temperature to 35°C ([@b22-molce-41-12-1052]) for an additional hour ([Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}, *Method (I)*). Notably, the mortality of worms co-treated with TCS and Tw20 significantly increased following the temperature upshift ([Fig. 4C](#f4-molce-41-12-1052){ref-type="fig"}, *Method (I)*). This seems to indicate that sequestered TCS molecules within Tw20 micelles were released upon temperature-mediated micelle disruption and regained their lethal activity. Furthermore, to rule out the contribution of extracellular TCS in the observed mortality following the upshift, extracellular TCS-Tw20 complexes were removed by repeated washing and L1 larvae were then upshifted to 35°C for an additional hour ([Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}, *Method (II)*). Under these conditions, up to \~30% increase in mortality in comparison to TW20-treated worms ([Fig. 4C](#f4-molce-41-12-1052){ref-type="fig"}, *Method (II)*) was observed, which is apparently attributed to the internalized TCS-Tw20 complexes.

The PMP-3/ABC transporter modulates the absorption, metabolism, and cytotoxicity of pharmacological agents ([@b8-molce-41-12-1052]). Of recent, we have reported that lack of PMP-3 increases susceptibility to TCS ([@b45-molce-41-12-1052]). A reporter gene analysis showed that *pmp-3 (promoter)::GFP* is expressed in the pharynx, muscles, intestine, and stem cell niche ([Supplementary Fig. S2](#s1-molce-41-12-1052){ref-type="supplementary-material"}). To ask if internalized TCS-Tw20 micelle complexes are exported out of the worms' bodies through PMP-3, L1 stage *pmp-3(ok1087)* loss-of-function mutant worms (*pmp-3(−)*) were treated as described in [Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}. As is the case with wild-type worms ([Fig. 4B](#f4-molce-41-12-1052){ref-type="fig"}), 1 mM TCS caused 100% mortality in *pmp-3(−)* mutant worms, which was significantly ameliorated in the presence of 0.1% of Tw20 ([Fig. 4D](#f4-molce-41-12-1052){ref-type="fig"}, *Pre-incubation*). Importantly, the mortality of *pmp-3(−)* mutants was significantly enhanced following heat-mediated micelle disruption, an effect that was significantly higher than that of their wild-type counterparts (*p* \< 0.01, compare [Figs. 4C and 4E](#f4-molce-41-12-1052){ref-type="fig"}, *Method (I)*). Next, to test if accumulated intracellular TCS could increase the mortality in *pmp-3(−)* mutant worms, we co-treated L1 staged *pmp-3(−)* mutant worms with 1 mM TCS and 0.1% Tw20 for 1 h at 25°C, before the temperature was upshifted to 35°C following washing for three times ([Fig. 4A](#f4-molce-41-12-1052){ref-type="fig"}, *Method (II)*). Interestingly, TCS molecules released from Tw20 micelles at 35°C significantly increased the mortality (76 ± 3.7%) of *pmp-3(−)* mutant worms more than that (34 ± 3.6%) seen in wild-type worms (*p* \< 0.01, compare *Method( II)* in [Figs. 4C and 4E](#f4-molce-41-12-1052){ref-type="fig"}).

Taken together, these results point at two possible conclusions: First, Tw20 may inhibit the toxicity of TCS by micellar solubilization. Second, export of internalized TCS-Tw20 micellar complexes may be facilitated, at least in part, through a PMP-3-mediated detoxification mechanism. Although only TCS was evaluated under these conditions, it is reasonable to suggest that a similar pattern is likely mirrored by other phenolic EDCs and NISs.

DISCUSSION
==========

EDCs are ubiquitous in the environment and pose a global threat to human and wildlife health*.* To date, studies elucidating the toxicity of EDCs have received greater attention from researchers, while investigations devoted to the identification of EDC inhibitors are only recently emerging. For instance, just a few years ago, Sengupta *et al.* reported that atrazine inhibits TCS toxicity by activating the nuclear receptor HR96 (an ortholog of CAR/PXP/VDR) in *Daphnia magna* ([@b35-molce-41-12-1052]). In addition, the interaction of surfactants with other antibacterials such as amoxicillin and moxifloxacin has previously been studied ([@b34-molce-41-12-1052]). However, no studies have investigated the protective role of NISs against EDC toxicity in eukaryotic model systems.

This work establishes the nematode *C. elegans* as a model for studying the toxicity of phenolic EDCs and also demonstrates the ameliorative potential of NISs against the mortality of TCS and other phenolic EDCs, facilitated through micellar solubilization. The TCS-micelle complex appears to be exported out of the worms' bodies at least in part through a PMP-3/ABC transporter ([Figs. 5A and 5B](#f5-molce-41-12-1052){ref-type="fig"}). However, following micelle disruption, released TCS seems to regain its activity and in turn perturbs the survival of worms ([Fig. 5C](#f5-molce-41-12-1052){ref-type="fig"}). In pharmaceutical and nutritional preparations, NISs have been used as solubilizers and stabilizers, but their potential effects on the detoxification of EDCs have largely been overlooked. Therefore, our findings present broad insights into EDC intoxication, detoxification, and drug formulation strategies.

The activity of phenolic compounds is influenced by their percent saturation in solution ([@b29-molce-41-12-1052]). Micelle aggregates are formed when surfactants are dissolved in solutions at or above their critical micelle concentration (CMC). Surfactants can solubilize phenolics in the micellar phase and thus reduce their thermodynamic activity ([@b1-molce-41-12-1052]). To put things into perspective, a saturated water solution of chloroxylenol, a phenolic disinfectant, was shown to exhibit comparable biocidal efficacy to a saturated surfactant solution with concentrations of many orders of magnitude higher ([@b26-molce-41-12-1052]). Moreover, Taylor et al. compared the efficacy of TCS against *E. coli* at 100% saturation in ammonium lauryl sulfate (ALS) solutions of varying concentrations ([@b38-molce-41-12-1052]). Interestingly, the degree of bacterial growth reduction when ALS was increased was similar to that observed when less ALS and twice as much TCS were used ([@b38-molce-41-12-1052]). This indicates that surfactant to EDC ratio, but not EDC concentration, determines the overall fate of EDC activity. Similarly, other phenolic antimicrobial agents, most notably rifampicin and isoeugenol, were found to be highly susceptible to inactivation by Tw80 ([@b28-molce-41-12-1052]). In *E. coli*, our data show that TCS retains its antibacterial activity at a minimum concentration of 0.001 mM when co-administered with 0.1% Tw20, suggesting that the bioavailable portion of TCS was sufficient to exhibit its bactericidal effect under these saturation conditions (see [Fig. 2E](#f2-molce-41-12-1052){ref-type="fig"}). This is corroborated by the contrasting synergistic effect of Tw80 on water-soluble antimicrobials such as polymyxin B and benzalkonium chloride ([@b40-molce-41-12-1052]). It is important to note that, because TCS in prokaryotes inhibits the synthesis of fatty acids, which are abundant in surfactants, it has been surmised that TCS-resistant *Staphylococcus aureus* compensate for TCS-induced anti-lipogenic effect by utilizing exogenous fatty acids presumably provided by the Tween surfactants ([@b27-molce-41-12-1052]). In *C. elegans*, manipulating the NIS-TCS ratio showed that NISs are potent inhibitors of phenolic EDCs at very low concentrations. Our results revealed that NIS concentrations as low as 0.0008% significantly reduced the mortality caused by a lethal TCS dose of 0.5 mM (see [Fig. 2C](#f2-molce-41-12-1052){ref-type="fig"}). This remarkable inhibitory efficiency, compared to that seen in *E. coli*, could be ascribed to the outer cuticle that encapsulates the worms and imparts environmental and anti-toxic protection.

In conclusion, the current study identifies NISs as potent inhibitors of phenolic EDCs in an eukaryotic model organism. The findings presented herein may pave the way for devising and developing potentially effective preventive and therapeutic strategies to control the widespread dissemination of phenolic EDCs, while still maintaining their beneficial antimicrobial properties. The observations presented here, along with those from previous studies, mandate further investigations based on a multidisciplinary approach, combining physicochemical and biological aspects, to fully characterize the direct interaction between NISs and EDCs. Future efforts should be directed toward investigating the complex interplay between NIS solubilization and its net effect on drug digestion, absorption, and overall activity in highly relevant vertebrate model systems.
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![TCS induces mortality of wild-type worms\
(A) Chemical structure of TCS. (B) Strategy for chemical treatment. (C and D) DIC pictures of wild-type worms in the absence or presence of TCS. (E and F) Percent mortality in TCS-treated wild-type L1 larvae. Standard deviation bars were calculated from at least three independent experiments (n\>300). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; N.S. (Not statistically significant).](molce-41-12-1052f1){#f1-molce-41-12-1052}

![Protective role of NISs against TCS\
(A) Effect of Tw20 on TCS-induced mortality in L1 larvae. (B) Effect of Tw20 on pharyngeal pumping. (C) Dose-dependent effect of TCS and Tw20 on mortality. (D) Effect of NISs on TCS-induced mortality. (E) Effect of Tw20 on the antimicrobial activity of TCS. Standard deviation bars were calculated from at least three independent experiments (n \> 300). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; N.S. (Not statistically significant).](molce-41-12-1052f2){#f2-molce-41-12-1052}

![NISs suppress the mortality induced by other phenolic EDCs\
(A) Chemical structures of non-EDCs and phenolic EDCs. (B--E) Effects of NISs on chemical toxicant-induced mortality. For NaN~3~ and BPA, total exposure period was 24 h at 25°C. For EtOH and B4HB, worms were treated for 1 h at 25°C. Standard deviation bars were calculated from at least three independent experiments (n \> 300). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; N.S. (Not statistically significant).](molce-41-12-1052f3){#f3-molce-41-12-1052}

![Tw20 inhibits TCS-induced mortality via micelle formation\
(A) Exposure strategy. (B, C) Effects of Tw20 micelle formation on TCS-induced mortality in wild-type worms. (D, E) Role of PMP-3 in the export of TCS-Tw20 micellar complex. Standard deviation bars were calculated from at least three independent experiments (n \> 300). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; N.S. (Not statistically significant).](molce-41-12-1052f4){#f4-molce-41-12-1052}

![A working model for NIS amelioration of EDC-induced mortality\
(A) EDCs can act via receptor-based mechanism, but at high doses, EDCs may employ receptor-independent mechanisms. EDCs (e.g., TCS) may also inhibit PMP-3-mediated detoxification mechanisms ([@b45-molce-41-12-1052]). (B) EDCs could be inactivated *in vivo* by NIS-mediated micellar solubilization and the EDC-NIS complex may be exported at least in part by PMP-3/ABC transporters. (C) Upon micelle disruption, liberated EDC molecules regain their toxicity and may inhibit PMP-3-mediated detoxification.](molce-41-12-1052f5){#f5-molce-41-12-1052}
